Hjem › Neuroblastom › Florida › Gainesville
Neuroblastom kliniske forsøg i Gainesville, FL
6 studier for Neuroblastom søger deltagere på steder i og omkring Gainesville (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- University of Florida, Gainesville
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- University of Florida, Gainesville
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- University of Florida, Gainesville
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RekruttererFase 1/2
- University of Florida, Gainesville
Neuroblastom forsøg i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Gainesville
- Hjertesvigt13 studier
- Brystkræft12 studier
- Type 1-diabetes12 studier
- Parkinsons sygdom12 studier
- Ikke-småcellet lungecancer10 studier
- Colorektal kræft9 studier
- Lungecancer9 studier
- Kræft (alle typer)9 studier
- Kardiovaskulær sygdom9 studier
- Prostatakræft8 studier
- Let kognitiv svækkelse8 studier
- Akut myeloid leukæmi8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.